Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M110,278Revenue $M17,005Net Margin (%)17.8Z-Score3.7
Enterprise Value $M107,956EPS $3.0Operating Margin %22.2F-Score5
P/E(ttm))24.6Cash Flow Per Share $4.4Pre-tax Margin (%)21.6Higher ROA y-yN
Price/Book5.510-y EBITDA Growth Rate %7.1Quick Ratio6.5Cash flow > EarningsY
Price/Sales4.45-y EBITDA Growth Rate %8.1Current Ratio6.8Lower Leverage y-yN
Price/Cash Flow9.7y-y EBITDA Growth Rate %-7.6ROA % (ttm)7.6Higher Current Ratio y-yY
Dividend Yield %1.6Insider Buy (3m)0ROE % (ttm)16.0Less Shares Outstanding y-yY
Payout Ratio %38.0Shares Outstanding M1,425ROI % (ttm)3.1Gross Margin Increase y-yN

Gurus Latest Trades with MDT

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MDTRichard Snow 2011-09-30 Reduce-2.58%$30.41 - $38.2
($34.75)
$ 77.3855%Reduce -98.85%20,235
MDTDavid Tepper 2010-09-30 Buy 1.41%$31.21 - $38.06
($35.14)
$ 77.3855%New holding1,411,974
MDTJohn Hussman 2014-12-31 Buy 1.4%$61.81 - $75.57
($69.56)
$ 77.3810%New holding200,000
MDTDavid Tepper 2011-09-30 Sold Out -1.3121%$30.41 - $38.2
($34.75)
$ 77.3855%Sold Out0
MDTWhitney Tilson 2012-09-30 Sold Out -1.3%$37.35 - $43.71
($40.31)
$ 77.3848%Sold Out0
MDTJohn Hussman 2013-03-31 Reduce-1.25%$41.02 - $47.22
($45.42)
$ 77.3841%Reduce -69.54%503,300
MDTJohn Hussman 2014-06-30 Sold Out -1.2%$58.05 - $64.67
($60.7)
$ 77.3822%Sold Out0
MDTJohn Paulson 2010-12-31 Buy 1.16%$33.21 - $37.62
($35.03)
$ 77.3855%New holding9,132,900
MDTRichard Snow 2009-06-30 Buy 1.06%$29.31 - $35.83
($32.56)
$ 77.3858%New holding595,748
MDTWhitney Tilson 2011-12-31 Add1.03%$31.79 - $38.34
($34.67)
$ 77.3855%Add 283.12%69,920
MDTRichard Snow 2009-12-31 Add1.01%$35.7 - $44.9
($40.26)
$ 77.3848%Add 102.19%1,222,033
MDTRobert Olstein 2014-06-30 Buy 0.99%$58.05 - $64.67
($60.7)
$ 77.3822%New holding115,000
MDTJames Barrow 2011-06-30 Add0.94%$37.92 - $43.2
($40.31)
$ 77.3848%Add 210.85%17,870,233
MDTArnold Van Den Berg 2010-06-30 Buy 0.91%$36.21 - $45.79
($41.44)
$ 77.3846%New holding282,760
MDTKen Fisher 2012-06-30 Reduce-0.91%$35.89 - $39.39
($37.69)
$ 77.3851%Reduce -99.31%60,541
MDTKen Fisher 2011-06-30 Add0.84%$37.92 - $43.2
($40.31)
$ 77.3848%Add 2563.22%8,611,921
MDTPRIMECAP Management 2014-12-31 Reduce-0.74%$61.81 - $75.57
($69.56)
$ 77.3810%Reduce -37.10%18,578,166
MDTArnold Van Den Berg 2014-03-31 Sold Out -0.72%$53.6 - $60.84
($58.15)
$ 77.3825%Sold Out0
MDTArnold Van Den Berg 2013-12-31 Reduce-0.7%$52.46 - $58.84
($56.74)
$ 77.3827%Reduce -49.89%133,283
MDTVanguard Health Care Fund 2011-09-30 Add0.69%$30.41 - $38.2
($34.75)
$ 77.3855%Add 52.77%11,001,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MDT is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


MDT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
TEN HOEDT ROBEVP & President EMEAC 2015-03-18Sell7,619$77.41-1.03view
ISHRAK OMARChairman & CEO 2015-03-13Sell20,000$76.240.49view
OLEARY DENISE MDirector 2015-02-26Sell368$78.85-2.84view
OConnell Christopher JEVP & GroupPres Restora Therap 2015-02-19Sell50,361$78.22-2.06view
Kuntz RichardSrVP & Chief Scien, Clin, Reg 2014-12-19Sell12,855$74.542.78view
JACKSON SHIRLEY ADirector 2014-12-02Sell1,102$74.432.93view
OConnell Christopher JEVP & GroupPres Restora Therap 2014-11-28Sell42,921$73.953.6view
COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc 2014-10-09Sell370$64.0719.57view
OConnell Christopher JEVP & GroupPres Restora Therap 2014-10-06Sell15,388$64.9817.9view
COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc 2014-10-03Sell571$65.0317.81view

Press Releases about MDT :

    Quarterly/Annual Reports about MDT:

    News about MDT:

    Articles On GuruFocus.com
    Freedom Fund Update – March 2015 Mar 02 2015 
    Medtronic (MDT) Momentum at All-Time-High Levels, Knowles (KN) Rating Boosted Feb 22 2015 
    Medtronic Q3 Earnings 2015 Exceeds Market Expectations Feb 19 2015 
    A Robust Q4 Earnings Report From Boston Scientific Feb 10 2015 
    A Look at John Hussman's Recent Additions to His Portfolio Feb 06 2015 
    Steven Romick Shorts Alibaba, Medtronic in Q4 Jan 20 2015 
    Toro: A Quality Company with Strong Prospects Dec 19 2014 
    Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
    Boston Scientific Lost the First Place in Innovation Dec 11 2014 
    Vycor Value Could be Unlocked with These Major Partnerships Dec 05 2014 


    More From Other Websites
    MedTech M&As Continue Regardless of Tax Scenarios - Industry Outlook Mar 26 2015
    Medtronic Completes Acquisition of Sophono, Inc., Minimally Invasive Bone Conduction Hearing Implant... Mar 26 2015
    Zacks Industry Outlook Highlights: Johnson & Johnson and Medtronic - Press Releases Mar 26 2015
    MedTech Industry Stock Outlook - March 2015 - Industry Outlook Mar 25 2015
    Medtronic Highlights New Data in JAMA Surgery Demonstrating Significant Cost Savings and Reduced... Mar 25 2015
    Medtronic Highlights New Data in JAMA Surgery Demonstrating Significant Cost Savings and Reduced... Mar 25 2015
    MedTech Industry Stock Outlook - March 2015 - Zacks Analyst Interviews Mar 25 2015
    Medtronic Global Fellows program touches down in Memphis Mar 25 2015
    12 Tech Stocks Investors Should Watch Mar 25 2015
    Medtronic Gains on Positive 2-Year CoreValve Trial Data - Analyst Blog Mar 20 2015
    Medtronic Up on Positive Preclinical Drug-Filled Stent Results - Analyst Blog Mar 19 2015
    Research and Markets: India Coronary Stents Market - Potential & Growth Forecast to 2019 Mar 19 2015
    New Hope for Stroke Boosts Demand for Device to Nab Clots Mar 19 2015
    Is St. Jude Medical Facing Palpitations? Mar 19 2015
    Protégé GPS Self-Expanding Peripheral Stent System Receives FDA Approval for Use in Treating Iliac... Mar 18 2015
    Target CEO keeps high-flying jet perk that other companies prohibit Mar 18 2015
    Notable option activity in equities Mar 18 2015
    Oppenheimer: Bullish Technical Analysis Of 5 Healthcare Names Mar 18 2015
    Medtronic Up on Positive CoreValve Evolut R Study Results - Analyst Blog Mar 17 2015
    Medtronic seeking marathoners with devices Mar 17 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK